Pronóstico del mercado de fraccionamiento de plasma de América del Sur hasta 2028: impacto de COVID-19 y análisis regional por producto (inmunoglobulina, albúmina, concentrados de factor de coagulación, inhibidores de proteasa y otros productos plasmáticos), aplicación (neurología, inmunología, hematología, cuidados intensivos, neumología y Otras aplicaciones) y usuario final (hospitales y clínicas, laboratorios de investigación clínica e institutos académicos)
Introducción al mercado
La región SAM para estimar el mercado de fraccionamiento de plasma consta de países como Brasil, Argentina y resto de SAM. Se espera que la región experimente oportunidades de crecimiento debido a la creciente incidencia de accidentes cerebrovasculares en los países y al mayor desarrollo de los sistemas de salud. También se espera que el mercado crezca debido a la creciente conciencia sobre los tumores y aneurismas cerebrales en los países de la región.
Ha habido un aumento en el número de casos en Países de la Región Samaria desde el inicio de la segunda ola de COVID-19. Según el Consejo Internacional de Enfermeras, debido a la alta transmisión del virus, el número de muertes entre profesionales de la salud en Brasil es mayor que en otras naciones. Actualmente, los países de la región SAM están incrementando rápidamente sus programas clínicos para luchar contra la COVID-19. En este escenario, las empresas farmacéuticas y biofarmacéuticas están haciendo hincapié en el desarrollo de nuevas terapias de tratamiento para el tratamiento de COVID-19, lo que está impactando negativamente en el mercado. Además, debido a los bloqueos impuestos en varios países de SAM, el suministro de sangre y productos relacionados también disminuyó ya que las personas no podían salir de sus hogares para donar. La disminución del suministro de sangre afectó negativamente a las empresas procesadoras de plasma. Por tanto, es probable que el brote de COVID-19 tenga un impacto negativo en el crecimiento del mercado.
Descripción general y dinámica del mercado
Se espera que el mercado de fraccionamiento de plasma en SAM crezca de US$ 1.955,98 millones en 2021 a US$ 2.663,87 millones en 2028; Se estima que crecerá a una tasa compuesta anual del 4,5% de 2021 a 2028. Los actores del mercado asociados con la metabolómica están explorando activamente las posibles tecnologías innovadoras para facilitar a los investigadores y la atención médica como el plasma que contiene los componentes esenciales para tratar una enfermedad, como los anticuerpos. . Se están realizando diversos estudios sobre las posibles aplicaciones del plasma en enfermedades difíciles de curar con métodos tradicionales. Además, se espera que la creciente conciencia sobre las ventajas de la donación de sangre y las aplicaciones de plasma entre las personas abra nuevas posibilidades para el mercado.
Segmentos de mercado clave
El mercado de fraccionamiento de plasma SAM está segmentado en producto, aplicación, usuario final y país. El mercado de fraccionamiento de plasma SAM, según producto, se ha segmentado en inmunoglobulinas, albúmina, concentrados de factores de coagulación, inhibidores de proteasa y otros. Es probable que el segmento de inmunoglobulinas tenga la mayor participación del mercado en 2021. El mercado de fraccionamiento de plasma SAM, según la aplicación, se segmenta en neurología, inmunología, hematología, cuidados intensivos, neumología y otros. En 2021, es probable que el segmento de Neurología tenga la mayor cuota de mercado. El mercado de fraccionamiento de plasma SAM, basado en el usuario final, se segmenta en hospitales y clínicas, laboratorios de investigación clínica e institutos académicos. En 2021, es probable que el segmento de hospitales y clínicas tenga la mayor participación del mercado. Según el país, el mercado de fraccionamiento de plasma de SAM está segmentado en Brasil, Argentina y el resto de SAM. Brasil tuvo la mayor participación de mercado en 2021.
Principales fuentes y empresas cotizadas
Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado de fraccionamiento de plasma en SAM son los sitios web de las empresas, los informes anuales, los informes financieros, los documentos del gobierno nacional y las bases de datos estadísticas, entre otros. Las principales empresas que figuran en el informe son Bharat Serums and Vaccines Limited (BSV); Laboratorio de Productos Bio Ltd.; Biotest AG; CSL limitada; Grifols, SA; Kedrion SpA; Octapharma AG; y SK Plasma.
Razones para comprar informe
- Comprender el panorama del mercado de fraccionamiento de plasma SAM e identificar los segmentos de mercado que son más probablemente garantice un fuerte retorno.
- Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado de fraccionamiento de plasma SAM.
- Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en el mercado de fraccionamiento de plasma SAM identificando segmentos de mercado con las ventas probables más prometedoras.
- Ayuda a tomar decisiones comerciales informadas desde una perspectiva perspicaz y análisis integral del desempeño del mercado de varios segmentos del mercado de fraccionamiento de plasma SAM.
- Obtener un pronóstico de ingresos de mercado para varios segmentos de 2021 a 2028 en la región SAM.
SAM Mercado de fraccionamiento de plasma Segmentación
Mercado de fraccionamiento de plasma SAM - Por producto
- Inmunoglobulina
- Inmunoglobulina intravenosa (IVIG)
- Inmunoglobulina subcutánea (SCIG) )
- Albúmina
- Concentrados de factor de coagulación
- Inhibidores de proteasa
- Otros
Mercado de fraccionamiento de plasma SAM - Por Aplicación
- Neurología
- Inmunología
- Hematología
- Cuidados críticos
- Neumología
- Otros
Mercado de fraccionamiento de plasma SAM: al final Usuario
- Hospitales y Clínicas
- Laboratorios de Investigación Clínica
- Institutos académicos
Mercado de fraccionamiento de plasma SAM - por país
- Brasil
- Argentina
- Resto de el mercado de fraccionamiento de plasma SAM
SAM: perfiles de empresas
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, SA
- Kedrion SpA
- Octapharma AG
- SK Plasma
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Plasma Fractionation Market – By Product
1.3.2 SAM Plasma Fractionation Market – By Application
1.3.3 SAM Plasma Fractionation Market – By End User
1.3.4 SAM Plasma Fractionation Market – By Country
2. SAM Plasma Fractionation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Plasma Fractionation Market – Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. SAM Plasma Fractionation Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Plasma Therapy is Becoming More Commonly Used
5.1.2 Rising Market Developments with Active Participation of the Players
5.2 Market Restraints
5.2.1 Competition from Non-Plasma Substitutes
5.3 Future Trends
5.3.1 Various Novel Diseases Getting Treated with the Use of Plasma Therapy
5.4 Impact Analysis
6. Plasma Fractionation Market – SAM Analysis
6.1 SAM Plasma Fractionation Market Revenue Forecast and Analysis
7. SAM Plasma Fractionation Market Revenue and Forecasts To 2028– by Product
7.1 Overview
7.2 SAM Plasma Fractionation Market, By Product 2021 & 2028 (%)
7.3 Immunoglobulin
7.3.1 Overview
7.3.2 Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.1 Intravenous Immunoglobulin (IVIG)
7.3.2.1.1 Overview
7.3.2.1.2 Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Subcutaneous Immunoglobulin (SCIG)
7.3.2.2.1 Overview
7.3.2.2.2 Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Albumin
7.4.1 Overview
7.4.2 Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Coagulation Factor Concentrates
7.5.1 Overview
7.5.2 Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Protease Inhibitors
7.6.1 Overview
7.6.2 Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Other Plasma Products
7.7.1 Overview
7.7.2 Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
8. SAM Plasma Fractionation Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 SAM Plasma Fractionation Market Share by Application 2021 & 2028 (%)
8.3 Neurology
8.3.1 Overview
8.3.2 Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Immunology
8.4.1 Overview
8.4.2 Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Hematology
8.5.1 Overview
8.5.2 Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Critical Care
8.6.1 Overview
8.6.2 Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Pulmonology
8.7.1 Overview
8.7.2 Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Other Applications
8.8.1 Overview
8.8.2 Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9. SAM Plasma Fractionation Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 SAM Plasma Fractionation Market Share by End User 2021 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Clinical Research Laboratories
9.4.1 Overview
9.4.2 Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Academic Institutes
9.5.1 Overview
9.5.2 Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
10. SAM Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis
10.1 Overview
10.1.1 SAM Plasma Fractionation Market, by Country, 2021 & 2028 (%)
10.1.1.1 Brazil: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Brazil: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3.1 Brazil: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4 Brazil: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.5 Brazil: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 Argentina: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Argentina: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3.1 Argentina: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4 Argentina: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.5 Argentina: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 Rest of SAM: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of SAM: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Rest of SAM: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3.1 Rest of SAM: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 Rest of SAM: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5 Rest of SAM: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on SAM Plasma Fractionation Market
11.1 SAM: Impact Assessment of COVID-19 Pandemic
12. Plasma Fractionation Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Followed by Major Market Players (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview
13. Company Profiles
13.1 Biotest AG.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Octapharma AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Kedrion S.p.A
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 CSL Limited
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Grifols, S.A.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bio Products Laboratory Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bharat Serums and Vaccines Limited (BSV)
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 SK Plasma
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Argentina: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6. Argentina: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. Argentina: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Rest of SAM: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 10. Rest of SAM: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Rest of SAM: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of SAM: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Organic Developments Done By Companies
Table 14. Inorganic developments done by Companies
Table 15. Glossary of Terms, SAM Plasma Fractionation Market
LIST OF FIGURES
Figure 1. SAM Plasma Fractionation Market Segmentation
Figure 2. SAM Plasma Fractionation Market Segmentation, By Country
Figure 3. SAM Plasma Fractionation Market Overview
Figure 4. Immunoglobulin Segment Held the Largest Share of the Product Segment in SAM Plasma Fractionation Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. SAM PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints Pertaining to SAM Plasma Fractionation Market
Figure 8. SAM Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. SAM Plasma Fractionation Market, by Product 2021 & 2028 (%)
Figure 10. SAM Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. SAM Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. SAM Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. SAM Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. SAM Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. SAM Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 16. SAM Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. SAM Plasma Fractionation Market Share by Application 2021 & 2028 (%)
Figure 18. SAM Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. SAM Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. SAM Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. SAM Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 22. SAM Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23. SAM Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24. SAM Plasma Fractionation Market Share by End User 2021 & 2028 (%)
Figure 25. SAM Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. SAM Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27. SAM Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28. SAM: Plasma Fractionation Market, By Key Country – Revenue (2021) (USD Million)
Figure 29. SAM: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
Figure 30. Brazil: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. Argentina: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. Rest of SAM: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. Impact of COVID-19 Pandemic in SAM Market
Figure 34. Growth Strategies Followed by Major Market Players (%)
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- SK Plasma
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the SAM plasma fractionation market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the SAM plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution